CEO Raymond De Vré
ZKB Analyst: Daniel Buchta
Group meeting, One-on-one, Small group meeting
PolyPeptide Group AG operates as a biotechnology company. The Company focuses on producing proprietary and generic GMP grade peptides for the pharmaceutical and biotechnology industry. PolyPeptide Group serves customers worldwide.
The following content is directed only to persons that meet below qualifications and have relevant professional experience and should not be acted on or relied on by other persons.
which qualifies as institutional client according to Article 4(4) of the Federal Act on Financial Services (FinSA) or as a professional client according to Article 4(3) FinSA.
the legal entity is authorised by the PRA or FCA or qualifies as any other investment professional falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005
or the legal entity has a share capital or net assets of at least £5 million or qualifies for other grounds as a high net worth company according to Article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005.
I am a natural person (retail client) or the company I'm acting for doesn't fit one of the categories above.
